Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big Pharma is coughing up cash to work with them on radiopharmaceuticals ...

DALLAS, April 1, 2022 /PRNewswire/ -- Sekisui Specialty Chemicals, provider of multiple chemical solutions, is excited to announce the launch of its new website, www.Advancell.com. Advancell ...

AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company takes its lead candidate through a prostate cancer trial. The Pb-212 ...

BRISBANE, Australia & INDIANAPOLIS, February 10, 2025--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an ...

SYDNEY, February 03, 2025--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an ...

Jacob Van Naarden, President of Lilly Oncology, added, "Partnering with AdvanCell aligns with our commitment to advancing innovative radiopharmaceuticals.We are excited to explore the potential of ...